No, Small Nodules on All Four Parathyroid Glands Do Not Always Mean Multiglandular Disease
The presence of small nodules on all four parathyroid glands does not automatically confirm multiglandular primary hyperparathyroidism—biochemical confirmation with elevated PTH and calcium is essential, and your patient's constellation of severe fatigue, sensory neuropathy, gait disturbance, and recurrent pancreatic atrophy strongly suggests this is symptomatic primary hyperparathyroidism requiring surgical evaluation.
Critical Diagnostic Framework
Biochemical Confirmation Takes Priority Over Imaging
The diagnosis of primary hyperparathyroidism (PHPT) requires:
- Elevated or inappropriately normal PTH in the context of hypercalcemia 1
- Imaging findings alone cannot establish the diagnosis
- Even "normal" PTH levels in the presence of hypercalcemia represent inappropriate secretion and suggest normo-hormonal PHPT 1
Your Patient's Symptoms Are Classic for PHPT
Severe fatigue is present in 63% of PHPT patients and correlates with more complex disease, including higher rates of multiglandular involvement 2. Patients presenting with fatigue are more likely to have:
- Multiglandular disease
- Normocalcemic PHPT
- Smaller parathyroid glands 2
Sensory neuropathy and coordination problems are documented neurologic manifestations of PHPT. While classic neuromuscular findings (weakness, atrophy, hyperreflexia) are rare in modern mild PHPT, paresthesias and sensory abnormalities occur in 52% of patients, with stocking-glove sensory loss and diminished reflexes documented in 29% 3. Severe sensorimotor polyneuropathy has been reported in PHPT 4.
Recurrent pancreatic atrophy strongly suggests recurrent pancreatitis from PHPT. PHPT-associated pancreatitis carries significantly worse outcomes than other etiologies, with 3.73-fold increased risk of severe acute pancreatitis and 12.76-fold increased mortality risk 5. Recurrent episodes without treatment lead to chronic pancreatitis 5, 6.
When to Suspect Multiglandular Disease
According to 2025 French guidelines, bilateral cervical exploration of all four glands is recommended when 7:
- Suspected multiglandular disease on imaging
- Young age (<40 years)
- Family history suggesting hereditary forms
- Known MEN1 or CDC73 mutations
- Non-contributory preoperative imaging
- Lithium-induced PHPT
18F-choline PET/CT is the preferred first-line examination when multiglandular disease is suspected 7, particularly in young patients or those with genetic predisposition.
Critical Pitfall: Imaging Alone Cannot Exclude Surgery
Do not delay parathyroidectomy based on inconclusive imaging 6. In confirmed PHPT with negative exhaustive imaging and no genetic argument for familial hypocalciuric hypercalcemia, exploratory cervicotomy by a trained surgical team should still be considered 7.
The case literature demonstrates that postponing surgery due to equivocal imaging while biochemical hyperparathyroidism persists leads to recurrent pancreatitis and worse outcomes 6.
Surgical Approach Based on Imaging Findings
If imaging suggests single-gland disease: selective (targeted) parathyroidectomy with intraoperative PTH monitoring 7
If imaging suggests multiglandular disease or is non-contributory: bilateral cervical exploration of all four glands 7
During surgery, if multiglandular disease is discovered or intraoperative PTH doesn't decrease appropriately, convert to bilateral exploration 7
MEN1 Considerations
If MEN1 is suspected (multiglandular disease in young patient, family history, pancreatic involvement):
- Subtotal parathyroidectomy (removing 3.5 glands) is standard of care 8
- Expect 40-60% recurrence rates over time 8
- Supernumerary glands occur in ~10% of MEN1 patients 8
- Total parathyroidectomy with autotransplantation is no longer recommended due to high risk of prolonged hypoparathyroidism 8
Immediate Action Required
Given your patient's severe symptoms and recurrent pancreatic involvement:
- Obtain serum calcium and PTH levels immediately—even "normal" PTH with elevated calcium confirms PHPT 1
- Refer urgently to experienced parathyroid surgeon—PHPT-associated pancreatitis has 12.76-fold increased mortality risk 5
- Do not wait for perfect imaging—biochemical confirmation plus symptoms mandate surgical evaluation 6
- Screen for MEN1 if multiglandular disease confirmed (genetic testing, pancreatic imaging for neuroendocrine tumors) 8
The combination of fatigue, neuropathy, mobility impairment, and recurrent pancreatic disease represents severe symptomatic PHPT requiring definitive surgical treatment regardless of whether one or multiple glands are involved.